LT2833884T - Ccr3-inhibitorių panaudojimas - Google Patents

Ccr3-inhibitorių panaudojimas

Info

Publication number
LT2833884T
LT2833884T LTEP13713199.1T LT13713199T LT2833884T LT 2833884 T LT2833884 T LT 2833884T LT 13713199 T LT13713199 T LT 13713199T LT 2833884 T LT2833884 T LT 2833884T
Authority
LT
Lithuania
Prior art keywords
ccr3
inhibitors
Prior art date
Application number
LTEP13713199.1T
Other languages
English (en)
Inventor
Michael Chadham Nivens
Thierry Bouyssou
Rolf Goeggel
Peter Seither
Original Assignee
Alkahest, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48040249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2833884(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alkahest, Inc. filed Critical Alkahest, Inc.
Publication of LT2833884T publication Critical patent/LT2833884T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
LTEP13713199.1T 2012-04-03 2013-04-02 Ccr3-inhibitorių panaudojimas LT2833884T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12162937 2012-04-03
PCT/EP2013/056864 WO2013149986A1 (en) 2012-04-03 2013-04-02 Use of ccr3-inhibitors

Publications (1)

Publication Number Publication Date
LT2833884T true LT2833884T (lt) 2020-09-10

Family

ID=48040249

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13713199.1T LT2833884T (lt) 2012-04-03 2013-04-02 Ccr3-inhibitorių panaudojimas

Country Status (27)

Country Link
US (5) US20130261153A1 (lt)
EP (2) EP3763369B1 (lt)
JP (2) JP2015512432A (lt)
KR (4) KR20200044988A (lt)
CN (2) CN110384699A (lt)
AU (1) AU2013245027B2 (lt)
BR (1) BR112014023795B1 (lt)
CA (1) CA2869269C (lt)
CL (1) CL2014002523A1 (lt)
CY (1) CY1123222T1 (lt)
DK (1) DK2833884T3 (lt)
EA (1) EA032263B1 (lt)
ES (1) ES2811554T3 (lt)
HR (1) HRP20201165T1 (lt)
HU (1) HUE051648T2 (lt)
IL (1) IL234262A (lt)
IN (1) IN2014DN06989A (lt)
LT (1) LT2833884T (lt)
MX (1) MX2014011786A (lt)
NZ (1) NZ628882A (lt)
PH (1) PH12014502239A1 (lt)
PL (1) PL2833884T3 (lt)
PT (1) PT2833884T (lt)
RS (1) RS60665B1 (lt)
SI (1) SI2833884T1 (lt)
WO (1) WO2013149986A1 (lt)
ZA (1) ZA201406082B (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278302B2 (en) 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (uk) 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
US8680280B2 (en) 2012-04-02 2014-03-25 Boehringer Ingelheim International Gmbh Process for the manufacturing of CRR inhibitors
US20130261153A1 (en) * 2012-04-03 2013-10-03 Boehringer Ingelheim International Gmbh Use of ccr3-inhibitors
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
EP3449866B1 (en) 2016-11-24 2021-10-20 Kirishima Seiko Co., Ltd. Orthodontic appliance
EA201992356A1 (ru) * 2017-04-05 2020-03-23 Алкахест Инк. Способ и композиция для лечения заболевания, связанного с сетчаткой глаза, с использованием ингибитора ccr3
EP3606525A4 (en) 2017-04-05 2020-09-09 Alkahest, Inc. METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED DISORDERS USING CCR3 INHIBITORS
JP2020536929A (ja) * 2017-10-13 2020-12-17 アルカヘスト，インコーポレイテッド Ｃｃｒ３阻害剤を用いた、そう痒症、乾皮症、及び関連疾患を治療するための方法及び組成物
EP3793602A4 (en) 2018-05-15 2022-04-20 Alkahest, Inc. TREATMENT OF DISEASE ASSOCIATED WITH THE AGING PROCESS WITH MODULATORS OF LEUKOTRIENA4 HYDROLASE
EA202190463A1 (ru) * 2018-09-26 2021-06-29 Алкахест, Инк. Способы и композиции для лечения ассоциированных со старением нарушений с применением ccr3-ингибиторов
AU2022376563A1 (en) 2021-11-01 2023-12-07 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
NZ521182A (en) * 2000-03-03 2004-11-26 Cambridge Antibody Tech Human antibodies against eotaxin comprising VH adn VL domains and their use
US20020151064A1 (en) * 2001-02-07 2002-10-17 Children's Hospital Medical Center Regulation of CCR3 expression
US8030003B2 (en) * 2004-12-07 2011-10-04 Children's Hospital Medical Center Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
US8008092B2 (en) * 2007-10-09 2011-08-30 University Of Kentucky Research Foundation CCR3 inhibition for ocular angiogenesis and macular degeneration
WO2010069979A1 (en) * 2008-12-16 2010-06-24 Nycomed Gmbh Pyran derivatives as ccr3 modulators
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
US8278302B2 (en) * 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
US8778616B2 (en) * 2009-05-26 2014-07-15 University Of Kentucky Research Foundation Method of using CCR3 binding agents to detect choroidal neovascularization
UA109290C2 (uk) * 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
US20130261153A1 (en) * 2012-04-03 2013-10-03 Boehringer Ingelheim International Gmbh Use of ccr3-inhibitors
US10213421B2 (en) * 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
WO2020115836A1 (ja) * 2018-12-05 2020-06-11 東浜工業株式会社 ブロワー装置

Also Published As

Publication number Publication date
SI2833884T1 (sl) 2020-10-30
IN2014DN06989A (lt) 2015-04-10
AU2013245027B2 (en) 2017-10-12
EP2833884A1 (en) 2015-02-11
BR112014023795B1 (pt) 2021-09-08
KR20220132012A (ko) 2022-09-29
KR20210063481A (ko) 2021-06-01
EA032263B1 (ru) 2019-05-31
KR20140144200A (ko) 2014-12-18
CN104220073A (zh) 2014-12-17
CA2869269C (en) 2020-06-30
EP3763369A1 (en) 2021-01-13
DK2833884T3 (da) 2020-08-10
JP2015512432A (ja) 2015-04-27
CA2869269A1 (en) 2013-10-10
EP3763369B1 (en) 2024-02-28
ZA201406082B (en) 2019-01-30
US20160081998A1 (en) 2016-03-24
RS60665B1 (sr) 2020-09-30
HRP20201165T1 (hr) 2020-12-11
PH12014502239A1 (en) 2014-12-15
HUE051648T2 (hu) 2021-03-29
BR112014023795A2 (lt) 2017-06-20
KR20200044988A (ko) 2020-04-29
CN110384699A (zh) 2019-10-29
EA201401083A1 (ru) 2015-03-31
JP2018080183A (ja) 2018-05-24
PT2833884T (pt) 2020-08-26
PL2833884T3 (pl) 2020-11-02
IL234262A (en) 2017-10-31
US20130261153A1 (en) 2013-10-03
CY1123222T1 (el) 2021-10-29
MX2014011786A (es) 2014-12-05
EP2833884B1 (en) 2020-05-20
US20150099783A1 (en) 2015-04-09
US20200375971A1 (en) 2020-12-03
US20170319567A1 (en) 2017-11-09
AU2013245027A1 (en) 2014-09-11
WO2013149986A1 (en) 2013-10-10
BR112014023795A8 (pt) 2017-10-10
CL2014002523A1 (es) 2015-01-23
ES2811554T3 (es) 2021-03-12
NZ628882A (en) 2016-05-27

Similar Documents

Publication Publication Date Title
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
HK1212701A1 (zh) 恩雜魯胺製劑
HK1208439A1 (en) 5-azaindazole compounds and methods of use 5-
EP2826473A4 (en) NEW USE OF PATCHOULOL
ZA201406082B (en) Use of ccr3-inhibitors
HK1209767A1 (en) Purification of iduronate-2-sulfatase -2-
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
GB201216800D0 (en) Novel use
IL236312A0 (en) Preparation of 18f-flucyclobin
EP2881113A4 (en) NEW APPLICATION OF POGOSTONE
HK1201270A1 (en) Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5--
EP2892529A4 (en) USES OF (-) - PERHEXILINE
IL239245A0 (en) A new use of Eclidenium
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
TWM433525U (en) Structure of calorifier
GB201206393D0 (en) Use
GB201217666D0 (en) Construction of surfaces
GB201212463D0 (en) Novel use
GB201202256D0 (en) Novel use
GB201213726D0 (en) Novel compounds and their use
GB201220595D0 (en) Keysafe application
GB201209895D0 (en) Use of a composition